The National Institute on Aging (NIA) has posted the report from its 2026 Dementia Care and Caregiving Research Summit, a virtual meeting held March 17 to 19, 2026, that set the agency's caregiving research priorities for the coming years. The report states that the economic burden of dementia is "substantial and likely underestimated," putting total annual U.S. costs at approximately $781 billion to $800 billion once direct medical and long-term care spending are combined with the value of unpaid family caregiving. The estimate is drawn from summit presentations and steering committee synthesis, not from a new study NIA conducted itself.
The Care Summit is the fourth in a series that began in 2017 and continued in 2020 and 2023; each has fed into updates of the NIH's AD/ADRD Research Implementation Milestones, the federal roadmap under the National Plan to Address Alzheimer's Disease. This year's sessions, co-chaired by Julie Bynum and Joseph Gaugler, were organized around five areas: the economic impacts of dementia on patients and care partners; the role of community and academic partnerships in caregiving research; development of rigorous, scalable care interventions; advances in data infrastructure; and dementia care coordination models such as the CMS GUIDE Model. Planning drew on a Pre-Care Summit Listening Session held December 10, 2025, with people living with dementia, care partners, and researchers.
Among the specific gaps the report flags: research using multi-payer administrative and survey data to track how health financing and insurance shift dementia's costs between families and other payers, and studies evaluating the economic case for investing in earlier detection at scale. The report also names existing data resources, including NHATS/NSOC, the NIA Data LINKATE Program, the LTC Data Cooperative, and the Gateway to Global Aging Data, while noting that data siloes and access barriers still limit their use. A recurring cross-cutting theme was the complexity of caregiving across dementia types beyond Alzheimer's disease, and the difficulty of moving interventions that work in trials into everyday, sustainable practice.
The report is a priority-setting document, not a completed trial or a new therapy. It reflects what an NIA steering committee and invited presenters judged to be the most pressing unanswered questions in caregiving science, based on discussion and public input rather than a single dataset or experiment. Which of these gaps get funded, and when, will depend on future NIH budget cycles and grant competitions, a process that typically unfolds over years.